Abstract
Pseudomonas aeruginosa is an important opportunistic pathogen. Strain FRD1 is a mucoid isolate from the sputum of a cystic fibrosis patient. It has been widely studied and has many different phenotypes compared to nonmucoid strains. Here, we present the draft genome sequence of P. aeruginosa strain FRD1 to gain insight into mucoid isolates.
GENOME ANNOUNCEMENT
Pseudomonas aeruginosa is an important opportunistic pathogen that can cause persistent chronic infections in cystic fibrosis (CF) patients and individuals with a compromised immune system. A mucoid phenotype, a consequence of overproduction of exopolysaccharides alginate, has been found in most P. aeruginosa isolates from chronically infected CF patients (1). Strain FRD1, a sputum mucoid isolate from a CF patient, has been well studied over the last few decades (2). Besides being mucoidy, it presents several different phenotypes compared to the nonmucoid P. aeruginosa strain, such as loss of motility and lack of lipopolysaccharide (LPS) O-side chains. To better understand the ecological versatility of this important pathogen and the link between genomic complexity and bacterial adaption in human lungs, we sequenced the whole genome of the FRD1 strain and further compared it with nonmucoid strain PAO1 and two other P. aeruginosa CF isolates, Pseudomonas LESB58 (3) and PA2192 (4).
The FRD1 genome sequence was accomplished using Illumina high throughput reads in a hybrid de novo assembly strategy. The open reading frames (ORFs) were predicted using Glimmer 3.02, and gene functions were predicted and classified into different metabolic pathways by BLASTing against the KEGG, COG, and TrEMBL databases. Approximately 368 Mb of raw data were obtained from FRD1 genome sequencing and further assembled into 16 scaffolds containing 31 contigs using SOAPdenovo.
FRD1 has 6.68 Mb of genome that comprises 6,269 genes, which covered 88.44% of the entire genome length. The FRD1 genome is larger than the genome of the nonmucoid PAO1 strain (6.63 Mb) (5), yet its G+C content is 66%, comparable with that of PAO1. Multiple genome alignment by Mauve showed that FRD1 has multiple large inverse fragments compared to that of PAO1. In addition, the FRD1 genome has better identity with CF isolates, strains Pseudomonas LESB58 and PA2192, which are both biofilm hyperproducers and devoid of motility (6, 7). Three large predicted gene islands, 1 prephage (~184 kb), and 1 putative cluster of regularly interspaced short palindromic repeats (CRISPR) were found in FRD1. A 67-kb gene island carrying pvdDIJ gene clusters was found in both FRD1 and Pseudomonas LESB58 strains, but not in PAO1. A 6-kb gene cluster encoding PAGI-7 was only found in FRD1, not in any of the other three strains.
The KEGG pathway showed that the largest group of proteins in FRD1 was involved in environmental processing-membrane transportation. Although FRD1 lacks the LPS B band O-antigen, the FRD1 genome contained all gene clusters for the synthesis of a B band O-antigen, which belongs to the serotype IV subgroup according to BLASTn results (8). FRD1 has genes encoding flagella or type IV pili, two important bacterial surface appendages for swimming and twitching motilities. BLASTp and polygenetic tree analysis (generated by MEGA 4) showed that FRD1 pilA (encoded pilin) belongs to group I of 5 pilA groups, which has a pilO downstream of pilA (9).
Nucleotide sequence accession numbers.
This whole-genome shotgun project of Pseudomonas aeruginosa strain FRD1 has been deposited at GenBank under the accession no. JYJZ00000000. The version described in this paper is the first version, JYJZ01000000.
ACKNOWLEDGMENTS
This work was supported by the National Basic Research Program of China (973 Program) 2014CB846002 (L.Z.M.), National Natural Science Foundation of China grant 31270177 (L.Z.M.), and National Natural Science Foundation of China grant 31200044 (D.W.).
Footnotes
Citation Wang D, Hildebrand F, Ye L, Wei Q, Ma LZ. 2015. Genome sequence of mucoid Pseudomonas aeruginosa strain FRD1. Genome Announc 3(2):e00376-15. doi:10.1128/genomeA.00376-15.
REFERENCES
- 1.Henry RL, Mellis CM, Petrovic L. 1992. Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis. Pediatr Pulmonol 12:158–161. doi: 10.1002/ppul.1950120306. [DOI] [PubMed] [Google Scholar]
- 2.Ohman DE, Chakrabarty AM. 1981. Genetic mapping of chromosomal determinants for the production of the exopolysaccharide alginate in a Pseudomonas aeruginosa cystic fibrosis isolate. Infect Immun 33:142–148. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Winstanley C, Langille MG, Fothergill JL, Kukavica-Ibrulj I, Paradis-Bleau C, Sanschagrin F, Thomson NR, Winsor GL, Quail MA, Lennard N, Bignell A, Clarke L, Seeger K, Saunders D, Harris D, Parkhill J, Hancock RE, Brinkman FS, Levesque RC. 2009. Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool epidemic strain of Pseudomonas aeruginosa. Genome Res 19:12–23. doi: 10.1101/gr.086082.108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Mathee K, Narasimhan G, Valdes C, Qiu X, Matewish JM, Koehrsen M, Rokas A, Yandava CN, Engels R, Zeng E, Olavarietta R, Doud M, Smith RS, Montgomery P, White JR, Godfrey PA, Kodira C, Birren B, Galagan JE, Lory S. 2008. Dynamics of Pseudomonas aeruginosa genome evolution. Proc Natl Acad Sci U S A 105:3100–3105. doi: 10.1073/pnas.0711982105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Smith K, Spencer D, Wong GK, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock RE, Lory S, Olson MV. 2000. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 406:959–964. doi: 10.1038/35023079. [DOI] [PubMed] [Google Scholar]
- 6.Salunkhe P, Smart CH, Morgan JA, Panagea S, Walshaw MJ, Hart CA, Geffers R, Tümmler B, Winstanley C. 2005. A cystic fibrosis epidemic strain of Pseudomonas aeruginosa displays enhanced virulence and antimicrobial resistance. J Bacteriol 187:4908–4920. doi: 10.1128/JB.187.14.4908-4920.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Pier GB, Matthews WJ Jr, Eardley DD. 1983. Immunochemical characterization of the mucoid exopolysaccharide of Pseudomonas aeruginosa. J Infect Dis 147:494–503. doi: 10.1093/infdis/147.3.494. [DOI] [PubMed] [Google Scholar]
- 8.Raymond CK, Sims EH, Kas A, Spencer DH, Kutyavin TV, Ivey RG, Zhou Y, Kaul R, Clendenning JB, Olson MV. 2002. Genetic variation at the O-antigen biosynthetic locus in Pseudomonas aeruginosa. J Bacteriol 184:3614–3622. doi: 10.1128/JB.184.13.3614-3622.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Kus JV, Tullis E, Cvitkovitch DG, Burrows LL. 2004. Significant differences in type IV pilin allele distribution among Pseudomonas aeruginosa isolates from cystic fibrosis (CF) versus non-CF patients. Microbiology 150:1315–1326. doi: 10.1099/mic.0.26822-0. [DOI] [PubMed] [Google Scholar]